ATF2 and liver cancer: Since MAPK14-mediated activation of MEK-ERK-signaling can functionally overcome sorafenib resistance [11], we hypothesized that miR-622 might represent a superior regulator of both RAS-RAF-ERK as well as MAPK14-ATF2-signaling pathways in liver cancer.